Lupus clinical trials in Oklahoma
9 studies for Lupus are looking for participants at sites in Oklahoma.
Cities in Oklahoma
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Oklahoma City
- Research Site, Oklahoma City
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 13, 2026 · NCT07430306A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Oklahoma Medical Research Foundation, Oklahoma City
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Nov 12, 2026 · NCT07409181A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Oklahoma Medical Research Foundation, Oklahoma City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 3, 2026 · NCT07438496A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Oklahoma Medical Research Foundation, Oklahoma City
RecruitingObservational study
Ages 16 and older · All sexes · Updated Nov 2, 2026 · NCT07175285A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50262, Oklahoma City
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Nov 2, 2026 · NCT06617325Safety of the Herpes Zoster Subunit Vaccine in Lupus
- Oklahoma Medical Research Foundation, Oklahoma City
RecruitingPhase 4
Ages 18 to 90 · All sexes · Updated Oct 28, 2026 · NCT05559671A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- Oklahoma Medical Research Foundation, Oklahoma City
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Sep 9, 2026 · NCT06875960Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Oklahoma Medical Research Foundation, Oklahoma City
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Aug 20, 2026 · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Oklahoma, Oklahoma City
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.